{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:12:26Z","timestamp":1791850346237,"version":"4.3.4"},"reference-count":21,"publisher":"Hindawi Limited","issue":"4","license":[{"start":{"date-parts":[[2013,4,17]],"date-time":"2013-04-17T00:00:00Z","timestamp":1366156800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2013,4,17]],"date-time":"2013-04-17T00:00:00Z","timestamp":1366156800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1111\/jcpt.12045","type":"journal-article","created":{"date-parts":[[2013,4,17]],"date-time":"2013-04-17T11:48:38Z","timestamp":1366199318000},"page":"286-293","source":"Crossref","is-referenced-by-count":62,"title":["Direct and indirect comparison of the efficacy and safety of adalimumab, etanercept, infliximab and golimumab in psoriatic arthritis"],"prefix":"10.1155","volume":"38","author":[{"given":"S.","family":"F\u00e9nix-Caballero","sequence":"first","affiliation":[{"name":"Pharmacy Department; Puerto Real Universitary Hospital; C\u00e1diz Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. J.","family":"Alegre-del Rey","sequence":"additional","affiliation":[{"name":"Pharmacy Department; Puerto Real Universitary Hospital; C\u00e1diz Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Casta\u00f1o-Lara","sequence":"additional","affiliation":[{"name":"Pharmacy Department; Ceuta Universitary Hospital; Ceuta Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Puigvent\u00f3s-Latorre","sequence":"additional","affiliation":[{"name":"Pharmacy Department; Son Espases Universitary Hospital; Palma de Mallorca Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Borrero-Rubio","sequence":"additional","affiliation":[{"name":"Pharmacy Department; Puerto Real Universitary Hospital; C\u00e1diz Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. F.","family":"L\u00f3pez-Vallejo","sequence":"additional","affiliation":[{"name":"Pharmacy Department; Puerto Real Universitary Hospital; C\u00e1diz Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2013,4,17]]},"reference":[{"key":"10.1111\/jcpt.12045-BIB0001|jcpt12045-cit-0001","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1002\/art.21870","article-title":"Alefacept in combination with methotrexate for the treatment of psoriatic arthritis: results of a randomized, double-blind, placebo-controlled study","volume":"54","author":"Mease","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1111\/jcpt.12045-BIB0002|jcpt12045-cit-0002","doi-asserted-by":"crossref","first-page":"c147","DOI":"10.1136\/bmj.c147","article-title":"Comparison of two etanercept regimens for treatment of psoriasis and psoriatic arthritis: PRESTA randomised double blind multicentre trial","volume":"340","author":"Sterry","year":"2010","journal-title":"BMJ"},{"key":"10.1111\/jcpt.12045-BIB0003|jcpt12045-cit-0003","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1002\/art.22805","article-title":"Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: Results from the induction and maintenance psoriatic arthritis clinical trial 2","volume":"56","author":"Heijde","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1111\/jcpt.12045-BIB0004|jcpt12045-cit-0004","first-page":"1","article-title":"Soluble biomarkers of cartilage and bone metabolism in early proof of concept trials in psoriatic arthritis: effects of adalimumab versus placebo","volume":"5","author":"Kuijk","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1111\/jcpt.12045-BIB0005|jcpt12045-cit-0005","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/art.23538","article-title":"Contemporary prevalence and incidence of work disability associated with rheumatoid arthritis in the US","volume":"59","author":"Allaire","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1111\/jcpt.12045-BIB0006|jcpt12045-cit-0006","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/ard.2006.057901","article-title":"Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial","volume":"66","author":"Gladman","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/jcpt.12045-BIB0007|jcpt12045-cit-0007","first-page":"36","article-title":"Psoriasis y artropat\u00eda psori\u00e1sica: epidemiolog\u00eda, manifestaciones cl\u00ednicas y enfermedades asociadas","volume":"1","author":"Kogan","year":"2010","journal-title":"Revista Latinoamericana de Psoriasis y Artritis Psori\u00e1sica"},{"issue":"suppl.31","key":"10.1111\/jcpt.12045-BIB0008|jcpt12045-cit-0008","first-page":"S154","article-title":"Window of opportunity in early rheumatoid arthritis: possibility of altering the disease process with early intervention","volume":"21","author":"Quinn","year":"2003","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl 3","key":"10.1111\/jcpt.12045-BIB0009|jcpt12045-cit-0009","first-page":"iii37","article-title":"Cytokine blockers in psoriatic arthritis","volume":"60","author":"Mease","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/jcpt.12045-BIB0010|jcpt12045-cit-0010","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/ard.2003.018085","article-title":"Early effects of tumour necrosis factor alpha blockade on skin and synovial tissue in patients with active psoriasis and psoriatic arthritis","volume":"63","author":"Goedkoop","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/jcpt.12045-BIB0011|jcpt12045-cit-0011","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/art.1780380602","article-title":"American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis","volume":"38","author":"Felson","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1111\/jcpt.12045-BIB0012|jcpt12045-cit-0012","volume-title":"Indirect treatment comparison [computer program]","author":"Wells","year":"2009"},{"key":"10.1111\/jcpt.12045-BIB0013|jcpt12045-cit-0013","unstructured":"Primo J Calculadora para metaan\u00e1lisis. CASPE http:\/\/www.redcaspe.org\/descargas\/fichero\/447"},{"key":"10.1111\/jcpt.12045-BIB0014|jcpt12045-cit-0014","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10067-009-1340-7","article-title":"Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs","volume":"29","author":"Atteno","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1111\/jcpt.12045-BIB0015|jcpt12045-cit-0015","first-page":"883","article-title":"Risks and benefits of tumor necrosis factor-alpha inhibitors in the management of psoriatic artritis: systematic review and meta-analysis of randomized controlled trials","volume":"35","author":"Saad","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1111\/jcpt.12045-BIB0016|jcpt12045-cit-0016","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1002\/art.21306","article-title":"Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis","volume":"52","author":"Mease","year":"2005","journal-title":"Arthr Rheum"},{"key":"10.1111\/jcpt.12045-BIB0017|jcpt12045-cit-0017","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1002\/art.20335","article-title":"Etanercept treatment of psoriatic arthritis. Safety, efficacy, and effect on disease progression","volume":"50","author":"Mease","year":"2004","journal-title":"Arthr Rheum"},{"key":"10.1111\/jcpt.12045-BIB0018|jcpt12045-cit-0018","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1136\/ard.2004.032268","article-title":"Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT-2 trial","volume":"64","author":"Antoni","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/jcpt.12045-BIB0019|jcpt12045-cit-0019","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/art.24403","article-title":"Golimumab, a New Human Tumor Necrosis Factor alpha Antibody, Administered Every Four Weeks as a Subcutaneous Injection in Psoriatic Arthritis","volume":"60","author":"Kavanaugh","year":"2009","journal-title":"Arthr Rheum"},{"key":"10.1111\/jcpt.12045-BIB0020|jcpt12045-cit-0020","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0025-7753(02)72393-2","article-title":"El intervalo de confianza: algo m\u00e1s que un valor de significaci\u00f3n estad\u00edstica","volume":"118","author":"Argim\u00f3n","year":"2002","journal-title":"Med Clin (Barcelona)"},{"key":"10.1111\/jcpt.12045-BIB0021|jcpt12045-cit-0021","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1157\/13113299","article-title":"Equivalencia Terap\u00e9utica: Concepto y niveles de evidencia","volume":"129","author":"Delgado","year":"2007","journal-title":"Med Clin (Barcelona)"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12045","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12045","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12045\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:04:54Z","timestamp":1671818694000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,17]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,8]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12045","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4,17]]}}}